Atypical Antipsychotics Induced Metabolic Syndrome
The use of atypical antipsychotics in patients with schizophrenia is tightly related to the metabolic abnormalities like weight gain, diabetes, dyslipidemia and/or hypertension. Beside of having unique receptor binding features, their heterogeneous receptor binding properties ara also involved in th...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Psikiyatride Güncel Yaklaşımlar
2015-03-01
|
Series: | Psikiyatride Güncel Yaklaşımlar |
Subjects: | |
Online Access: | http://www.cappsy.org/archives/vol7/no1/cap_07_01_07.pdf |